-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 C/iEQLLfv+h8/3vZEET2JF7bk3Tw0V6+Qv8u4jYTo4vNi+WDPqZo/ob57D/CcEEa
 gpkSuDWGHxaX2QUst4lzQw==

<SEC-DOCUMENT>0001286774-09-000006.txt : 20091221
<SEC-HEADER>0001286774-09-000006.hdr.sgml : 20091221
<ACCEPTANCE-DATETIME>20091218192038
ACCESSION NUMBER:		0001286774-09-000006
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20091221
DATE AS OF CHANGE:		20091218
EFFECTIVENESS DATE:		20091221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONDINE BIOPHARMA Corp
		CENTRAL INDEX KEY:			0001286774
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-64540
		FILM NUMBER:		091251221

	BUSINESS ADDRESS:	
		STREET 1:		910-1100 MELVILLE ST
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E4A6
		BUSINESS PHONE:		604-669-0555

	MAIL ADDRESS:	
		STREET 1:		910-1100 MELVILLE ST
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E4A6

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONDINE BIOPHARMA CORP
		DATE OF NAME CHANGE:	20040412
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001286774</cik>
        <entityName>ONDINE BIOPHARMA Corp</entityName>
        <issuerAddress>
            <street1>910-1100 MELVILLE ST</street1>
            <city>VANCOUVER</city>
            <stateOrCountry>A1</stateOrCountry>
            <zipCode>V6E4A6</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>604-669-0555</issuerPhoneNumber>
        <jurisdictionOfInc>BRITISH COLUMBIA, CANADA</jurisdictionOfInc>
        <edgarPreviousNameList>
            <previousName>ONDINE BIOPHARMA CORP</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>William</firstName>
                <lastName>Harper</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Nicholas</firstName>
                <lastName>Loebel</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Thomas</firstName>
                <lastName>Dawson</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Merrill</firstName>
                <lastName>Biel</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Terence</firstName>
                <lastName>Holland</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Margaret</firstName>
                <lastName>Shaw</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Colin</firstName>
                <lastName>Watt</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Michael</firstName>
                <lastName>Crane</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>910-1100 Melville Street</street1>
                <city>Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <zipCode>V6E 4A6</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>$1 - $1,000,000</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-12-07</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isOtherType>true</isOtherType>
            <descriptionOfOtherType>9,322,588 common shares and rights to receive an additional 11,187,105 common shares subject to attainment of certain intellectual property milestones.  See also Items 10 and 13 for more information.</descriptionOfOtherType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>true</isBusinessCombinationTransaction>
            <clarificationOfResponse>This offering consisits of common shares and rights to receive additional common shares in connection with the acquisition of Advanced Photodynamic Technologies, Inc. a MN corporation, and a R&amp;D agreement with PhotoBiologix, Inc., a MN corporation</clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>480183</totalOfferingAmount>
            <totalAmountSold>480183</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse>Amounts consist of US$ value of 9,322,588 shares issued at C$0.055 per share. US$ value of rights issued for an additional 11,187,105 shares in connection with acquisition is undetermined. Bank of CAD daily noon ex. rate is 1 CAD=0.9365 U.S. on Dec 18/09.</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>4</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>ONDINE BIOPHARMA Corp</issuerName>
                <signatureName>William S. Harper</signatureName>
                <nameOfSigner>William S. Harper</nameOfSigner>
                <signatureTitle>Chief Financial Officer and Corporate Secretary</signatureTitle>
                <signatureDate>2009-12-18</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----